Paper36901890
A Unique In Vitro Assay to Investigate ABCB4 Transport Function.
Temesszentandrási-Ambrus C and 3 others. Int J Mol Sci, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. A Unique In Vitro Assay to Investigate ABCB4 Transport Function. Papers, record 36901890. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901890
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholestasis | Major topic |
| Chemical and Drug Induced Liver Injury | Major topic |
| Humans | |
| Polymorphism, Genetic | |
| Amino Acid Sequence | |
| Bile |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12429346 | Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. | Biochem Pharmacol | 2002 | https://conductscience.org/library/papers/12429346 | PubMed |
| 2 | 11375950 | LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11375950 | PubMed |
| 3 | 15975683 | Enterohepatic transport of bile salts and genetics of cholestasis. | J Hepatol | 2005 | https://conductscience.org/library/papers/15975683 | PubMed |
| 4 | 16651435 | Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo. | Cancer Res | 2006 | https://conductscience.org/library/papers/16651435 | PubMed |
| 5 | 18723475 | Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/18723475 | PubMed |
| 6 | 29708070 | Drug-induced Cholestasis: Mechanisms, Models, and Markers. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29708070 | PubMed |
| 7 | 9732409 | Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. | J Pharmacol Exp Ther | 1998 | https://conductscience.org/library/papers/9732409 | PubMed |
| 8 | 29777275 | Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro. | Cancer Chemother Pharmacol | 2018 | https://conductscience.org/library/papers/29777275 | PubMed |
| 9 | 24140176 | Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines. | Biomed Pharmacother | 2014 | https://conductscience.org/library/papers/24140176 | PubMed |
| 10 | 33017281 | Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartments. | Immunol Med | 2021 | https://conductscience.org/library/papers/33017281 | PubMed |
| 11 | 17523162 | Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4. | Hepatology | 2007 | https://conductscience.org/library/papers/17523162 | PubMed |
| 12 | 33435273 | Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33435273 | PubMed |
| 13 | 12708479 | Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. | Cancer Sci | 2003 | https://conductscience.org/library/papers/12708479 | PubMed |
| 14 | 27664577 | Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters. | Toxicol Appl Pharmacol | 2016 | https://conductscience.org/library/papers/27664577 | PubMed |
| 15 | 31484654 | Glutathione Conjugation and Protein Adduction Derived from Oxidative Debromination of Benzbromarone in Mice. | Drug Metab Dispos | 2019 | https://conductscience.org/library/papers/31484654 | PubMed |
| 16 | 31748707 | Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31748707 | PubMed |
| 17 | 2254635 | Criteria of drug-induced liver disorders. Report of an international consensus meeting. | J Hepatol | 1990 | https://conductscience.org/library/papers/2254635 | PubMed |
| 18 | 1352973 | Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. | Biochem Pharmacol | 1992 | https://conductscience.org/library/papers/1352973 | PubMed |
| 19 | 28437613 | Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. | Chem Res Toxicol | 2017 | https://conductscience.org/library/papers/28437613 | PubMed |
| 20 | 18668443 | Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions. | Xenobiotica | 2008 | https://conductscience.org/library/papers/18668443 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38931858 | Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931858 | PubMed |
| 38226983 | Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. | Cancer Chemother Pharmacol | 2024 | https://conductscience.org/library/papers/38226983 | PubMed |
| 37108379 | Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease and Disease Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108379 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCB4 | 5244 | PubTator's text mining | https://conductscience.org/library/genes/5244 | NCBI Gene |
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 | NCBI Gene |
| SLCO1B3 | 28234 | PubTator's text mining | https://conductscience.org/library/genes/28234 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901890
GET https://conductscience.org/api/papers/v1/36901890/references?page=2